<DOC>
	<DOCNO>NCT00720070</DOCNO>
	<brief_summary>RATIONALE : Imaging procedure , PET/CT scan , produce picture area inside body may help doctor detect residual disease plan best treatment . Neck dissection surgery remove lymph node tissue neck . It yet know whether neck dissection always perform treat patient head neck cancer . PURPOSE : This randomized phase III trial study PET/CT scan-guided watchful waiting compare neck dissection locally advance lymph node metastasis treat patient undergo chemotherapy radiation therapy primary head neck cancer .</brief_summary>
	<brief_title>PET/CT Scan-Guided Watchful Waiting Neck Dissection Locally Advanced Lymph Node Metastases Treating Patients Undergoing Chemotherapy Radiation Therapy Primary Head And Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To compare efficacy , term overall survival , disease-specific survival , recurrence , quality life , cost-effectiveness , PET/CT scan-guided watch wait policy current practice plan neck dissection management advance ( N2 N3 ) nodal metastases patient primary head neck squamous cell carcinoma undergo chemoradiotherapy . - To assess predictive value PET/CT scan detect persistent residual disease primary site . OUTLINE : This multicenter study . Patients stratify accord center , chemotherapy schedule ( concurrent platinum v concurrent cetuximab v neoadjuvant concurrent platinum v neoadjuvant docetaxel , platinum , fluorouracil concurrent platinum ) , T stage ( T1-T2 v T3-T4 ) , N stage ( N2a-N2b v N2c-N3 ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive standard concurrent chemoradiotherapy ( CRT ) . Patients undergo PET/CT scan 9-13 week completion CRT . Patients complete response primary site undergo neck dissection within 4 week . - Arm II : Patients undergo neck dissection receive standard CRT . Patients undergo PET/CT scan 9-13 week completion CRT . Patients assess periodically quality-of-life . Tissue blood sample collect periodically stored future research . After completion study treatment , patient follow monthly 1 year bimonthly 1 year .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm head neck squamous cell carcinoma ( HNSCC ) , include follow subtypes : Oropharyngeal Laryngeal Oral Hypopharyngeal No primary nasopharyngeal carcinoma Must clinical CT/MRI evidence nodal metastasis stag N2 ( , b , c ) N3 No occult nodal metastasis ( i.e. , large nodal metastasis proven primary site clinical assessment ) No N1 nodal metastasis Planning receive curative radical concurrent chemoradiotherapy ( approve study ) primary disease Patients undergoing neoadjuvant chemotherapy follow concurrent chemoradiotherapy eligible Able undergo neck dissection surgery No current resection primary tumor plan ( e.g. , resection tonsil base tongue flap reconstruction [ diagnostic tonsillectomy allow ] ) No distant metastasis chest , liver , bone , sit PATIENT CHARACTERISTICS : Not pregnant No cancer diagnosis within past 5 year except basal cell carcinoma cervical carcinoma situ PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior treatment HNSCC No concurrent neoadjuvant chemoradiotherapy without concurrent chemotherapy No concurrent adjuvant chemotherapy No concurrent chemoradiotherapy palliative purpose No concurrent radiotherapy alone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>stage I squamous cell carcinoma oropharynx</keyword>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage I squamous cell carcinoma larynx</keyword>
	<keyword>stage I verrucous carcinoma larynx</keyword>
	<keyword>stage II squamous cell carcinoma larynx</keyword>
	<keyword>stage II verrucous carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III verrucous carcinoma larynx</keyword>
	<keyword>stage I squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage I verrucous carcinoma oral cavity</keyword>
	<keyword>stage II squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage II verrucous carcinoma oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III verrucous carcinoma oral cavity</keyword>
	<keyword>stage I squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage II squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>tongue cancer</keyword>
</DOC>